← Leaderboards
Abha Sahni
University Of Texas Med Br Galveston
$845,125
Attributed
$1,058,250
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $434.5K · FY2016–22$500K$375K$250K$125K$0
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$1,058,250 · 3
By mechanism
R21$1,058,250 · 3
Top collaborators
- Sanjeev Sahni2 shared
Most similar at University Of Texas Med Br Galveston
Same institution · by research overlap
- Hema Prasad Narra$1,795,245
- Rong Megan Fang$4,698,806
- Bin Gong$3,540,307
- Yuejin Liang$1,140,349
Others in their field
Top investigators on “Tissues”
- David Heimbrook · Leidos Biomedical Research, Inc.$346,311,904
- Lawrence Corey · Fred Hutchinson Cancer Center$230,011,824
- Larry Arthur$159,140,370
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Judith S. Currier · University Of California Los Angeles$138,805,403
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$138,805,403
Research focus
TissuesInflammationRickettsiaMolecularCellsInfectionIn VitroRegulationVascular PermeabilitiesEndothelial CellsMouse ModelCommunicable DiseasesOrganPathogenesisPathogenicityGene ExpressionBrainHuman DiseasePreventDisease ProgressionLungDefined ContributionBloodMediating
Grant awards (5)
Defining the roles of an enhancer long non-coding RNA eIncRNA-ID2 in rickettsial pathogenesis and immunity$197,500
R21 · FY2022 · AI · contact PI
Defining the roles of an enhancer long non-coding RNA eIncRNA-ID2 in rickettsial pathogenesis and immunity$237,000
R21 · FY2021 · AI · contact PI
Role of mTOR signaling in endothelial responses to Rickettsia rickettsii infection.$197,500
R21 · FY2021 · AI · contact PI
Novel Therapeutic Target(s) for Pathogenic Rickettsia Species$193,750
R21 · FY2017 · AI
Novel Therapeutic Target(s) for Pathogenic Rickettsia Species$232,500
R21 · FY2016 · AI